Don't want ads? Subscribe or login now.

Novartis Inks $390M FCA Deal Over Pharmacy Discounts

By Jeff Overley · October 27, 2015, 11:13 AM EDT

Novartis AG on Tuesday said it has tentatively agreed to shell out $390 million to end a whistleblower's False Claims Act suit alleging improper kickbacks to pharmacies to boost sales of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

United States of America, ex rel, et al v. Novartis Pharmaceuticals Corporation

Case Number

1:11-cv-08196

Court

New York Southern

Nature of Suit

Other Statutes: False Claims Act

Date Filed

November 14, 2011

Recent Articles By Jeff

July 01, 2024
Supreme Court Widens Window To Challenge Federal Regs
June 29, 2024
Chevron's End Is Just The Start For Energized Agency Foes
May 17, 2024
Industry Emboldened After Justices Galvanize Agency Attacks
March 26, 2024
Jackson Paints Abortion Clash As Microcosm Of Bigger Brawl
February 21, 2024
Liberal Justices Hint Chevron Deference Hanging By A Thread
January 18, 2024
'Chaos' Warning Resonates As Justices Mull Chevron's Fate
October 18, 2023
Novartis Airs Mea Culpa As 2nd Circ. Probes Kickback Theory
September 29, 2023
'Administrative State' Attacks Soar To High Court Crescendo
September 15, 2023
High Court's New FCA Ruling Is Quickly Making Trials Likelier
July 21, 2023
The Litigation Jolting Health & Life Sciences In 2023's 2nd Half